BPC-157 10mg + TB500 10mg
BPC-157 / TB-500 Blend (RUO) | High Purity ≥99% | Research Grade
Product Specifications
| Specification | Details |
|---|---|
| Product Name | BPC-157 / TB-500 Research Blend |
| Blend Content | 10mg BPC-157 + 10mg TB-500 (20mg Total) |
| BPC-157 CAS | 137525-51-0 |
| TB-500 CAS | 885340-08-9 |
| BPC-157 Type | Synthetic Pentadecapeptide (15 Amino Acids) |
| TB-500 Type | Thymosin Beta-4 Fragment — Ac-LKKTETQ (7 Amino Acids) |
| Purity | ≥99% (HPLC Verified) |
| Form | Co-Lyophilized Powder |
| Solubility | Bacteriostatic Water |
| Storage | −20°C, Protected from Light and Moisture |
What Is BPC-157 / TB-500?
BPC-157 / TB-500 is a precision co-lyophilized research blend combining two well-characterized peptides in a fixed 1:1 ratio, supplied exclusively for laboratory and preclinical research applications. Each component operates through a distinct and complementary mechanistic pathway, making this blend widely referenced in peptide research literature for dual-pathway studies investigating angiogenic signaling and cytoskeletal reorganization within a single controlled experimental system.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, characterized in research literature for its activity at the VEGF/VEGFR2-Akt-eNOS signaling axis and nitric oxide (NO) system modulation. TB-500 is a synthetic fragment of thymosin beta-4 (residues 17–23, sequence Ac-LKKTETQ) studied for its role in actin sequestration and cytoskeletal organization — specifically the regulation of G-actin to F-actin polymerization balance that governs cell morphology and migration.
Co-lyophilization in a predefined 1:1 ratio delivers both mechanisms in a single vial, reducing preparation variability and minimizing measurement errors associated with manual dual-peptide preparation. This format is particularly suited to high-throughput research protocols and laboratories conducting extended experimental series requiring consistent dual-component dosing across multiple trial phases.
This product is clearly labeled and distributed strictly as a Research Use Only (RUO) material and is not approved for human or veterinary use.
Experimental Research Applications
In scientific literature, BPC-157 and TB-500 have been investigated individually and in combination in a variety of experimental settings, including:
- Angiogenic signaling and VEGF/VEGFR2-Akt-eNOS pathway research
- Nitric oxide (NO) system regulation studies
- Actin polymerization and cytoskeletal organization research
- Cell migration and motility assay models
- Extracellular matrix (ECM) remodeling investigations
- Fibroblast viability and stress response studies
- Dual-pathway synergistic signaling assay research
- Tissue-level repair mechanism investigations
These studies are conducted exclusively within laboratory and preclinical environments and are intended for mechanistic and observational research purposes.
Purity and Quality Control
Each batch of BPC-157 / TB-500 undergoes analytical testing to ensure:
✔ ≥99% purity verified by HPLC for each component
✔ Precise 1:1 co-lyophilized ratio (10mg BPC-157 : 10mg TB-500)
✔ Batch-to-batch consistency
✔ Professional documentation and traceability
✔ Controlled manufacturing standards
✔ Reliable performance for repeatable research applications
High analytical purity and strict quality control procedures help provide researchers with confidence in the consistency and reliability of each batch.
Key Research Features
- Dual-mechanism research blend — angiogenic + cytoskeletal pathways
- BPC-157: VEGF/VEGFR2-Akt-eNOS axis and NO system modulation
- TB-500: actin sequestration and G-actin/F-actin polymerization balance
- Precision co-lyophilized 1:1 ratio — minimizes preparation variability
- 20mg total content — suited for high-throughput and extended protocols
- ≥99% HPLC-verified purity per component
- Lyophilized powder format
- Suitable for in vitro and preclinical research
- Batch-tested for consistency
- Research-grade manufacturing standards
- Professionally labeled and documented
Storage Recommendations
To maintain product stability and research integrity, BPC-157 / TB-500 should be:
- Stored at −20°C in a tightly sealed container
- Reconstituted with sterile bacteriostatic water, added slowly along the vial wall with gentle swirling — avoid vigorous shaking
- Protected from light and moisture
- Kept sealed until use
- Handled according to standard laboratory procedures
- Not subjected to repeated freeze-thaw cycles
Toxicology and Regulatory Information
- BPC-157 evaluated in preclinical toxicology research models
- BPC-157 listed by the U.S. FDA as a Category 2 bulk substance (503A/503B compounding lists)
- Both BPC-157 and TB-500 included on the World Anti-Doping Agency (WADA) Prohibited List under Peptide Hormones, Growth Factors, Related Substances, and Mimetics
- Supplied strictly as a Research Use Only (RUO) material
- PPE required: nitrile gloves, lab coat, protective eyewear; refer to SDS for CAS 137525-51-0 and 885340-08-9
Why Choose Summit Pep Labs?
At Summit Pep Labs, we are committed to supplying researchers with premium-quality compounds manufactured to rigorous analytical standards.
Why Researchers Choose Summit Pep Labs
- ≥99% HPLC-verified purity per component
- Precision co-lyophilized 1:1 ratio — consistent dual-component delivery
- Batch consistency and traceability
- Professional labeling and packaging
- Research-grade manufacturing standards
- Secure cold-chain shipping and quality assurance
- Commitment to reproducibility and reliability
Frequently Asked Questions
What is BPC-157 / TB-500?
BPC-157 / TB-500 is a co-lyophilized research blend combining a synthetic pentadecapeptide (BPC-157) and a thymosin beta-4 fragment (TB-500) in a fixed 1:1 ratio, commonly referenced in scientific literature for dual-pathway studies investigating angiogenic signaling and cytoskeletal reorganization.
Why combine BPC-157 and TB-500 in a single blend?
The two peptides operate through distinct, complementary mechanisms. BPC-157 is characterized for its activity at angiogenic and NO signaling pathways, while TB-500 is studied for its role in actin dynamics and cell migration. A co-lyophilized blend allows researchers to investigate both pathways simultaneously in a single controlled system while eliminating the preparation variability associated with manual dual-peptide mixing.
Is TB-500 the same as thymosin beta-4?
No. Thymosin beta-4 is a 43-amino acid full-length peptide. TB-500 refers specifically to a synthetic fragment (residues 17–23, sequence Ac-LKKTETQ) containing the core actin-interacting motif. This blend uses the active fragment to allow research focused on the functionally characterized region without working with the full-length peptide.
Is BPC-157 / TB-500 approved for human use?
No. This blend is not approved by the FDA for human or veterinary use. BPC-157 is classified as a Category 2 bulk substance. Both compounds are supplied exclusively for research purposes.
What purity does Summit Pep Labs provide?
Each batch is tested and verified to contain ≥99% purity per component using HPLC analytical methods.
How is BPC-157 / TB-500 supplied?
The blend is supplied as a co-lyophilized powder containing 10mg BPC-157 and 10mg TB-500 per vial, packaged according to professional research standards.
How should BPC-157 / TB-500 be stored and reconstituted?
Store at −20°C, protected from light and moisture. Reconstitute using sterile bacteriostatic water, adding solvent slowly along the vial wall and swirling gently. Avoid vigorous shaking. Store reconstituted material at −20°C in single-use aliquots and avoid repeated freeze-thaw cycles.
References
- PubChem CID 9941957 — BPC-157 (Pentadecapeptide)
- PubChem CID 16132341 — TB-500 Fragment (Ac-LKKTETQ)
- National Center for Biotechnology Information (NCBI)
- U.S. Food and Drug Administration (FDA) — Category 2 Bulk Drug Substances
- World Anti-Doping Agency (WADA) Prohibited List
- Journal of Orthopaedic Research
- ICH Guidelines for Non-Clinical Safety Studies
Research Use Only Disclaimer
For Research Use Only (RUO).
This product is intended strictly for laboratory and scientific research purposes. It is not intended for human consumption, veterinary use, cosmetic applications, therapeutic use, or diagnostic purposes.
By purchasing this product, customers acknowledge that they are qualified researchers and agree to use these materials in accordance with all applicable laws and regulations.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.